Novozymes A/s: (OTC: NVZMY)
$34.26
-0.29 (-0.84%)
Volume 6,975
May 17 03:48 PM ET
Zacks Rank: 4-Sell 
| #4 |
Overview Quote
Stock Activity
| Day Low - High | 34.14 - 34.40 |
| 52wk Low - High | 23.73 - 36.36 |
| Previous Close | 34.55 |
| Avg. Volume | 6,808 |
| Industry | CHEM-SPECIALTY |
| Market Cap | 9.29 B |
| Div - Yield | 0.25 - 0.74 |
| Beta | 0.13 |
| PE (Forward) | 28.31 |
| Current Year Est. | 1.21 |
| Quarterly Earnings ESP |
NA |
Premium research
Zacks Rank
|
 4 |
Zacks Recommendation
|
No Zacks Recommendation |
Zacks Industry Rank
|
191 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| PE (Forward) | 28.31 |
| PEG Ratio | 2.27 |
| Current Year Est. | 1.21 |
| Current Quarter Estimate | 0.31 |
| Most Accurate Estimate | NA |
| Earnings ESP |
NA |
| Next Earnings Report Date | 08-15-2013 |
| EPS Last Year | 1.01 |
| Expected Earnings Growth | 12.50% |
Company Description
Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company's enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the transformation of starch into different kinds of sugars and have application in leather, textile, and forest product industries, food enzymes used in production of bread, wine, juice, beer, noodles, alcohol, and pasta and feed enzymes used in animal feed. Its bio business segment offers microorganisms that are used in industrial and municipal wastewater treatment, as well as in the cleaning of surfaces such as carpet, concrete, drain lines, and septic tanks in industrial and household applications. It also has application in the Biopharmaceutical ingredients used in pharmaceutical industry. Novozymes A/S is headquartered in Bagsvaerd, Denmark.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (06/2013) |
Next Qtr (09/2013) |
Current Year (12/2013) |
Next Year (12/2014) |
|
|---|---|---|---|---|
| Average Estimate | 0.31 | 0.33 | 1.21 | 1.31 |
| Number of Estimates | 1 | 1 | 1 | 1 |
| Low Estimate | 0.31 | 0.33 | 1.21 | 1.31 |
| High Estimate | 0.31 | 0.33 | 1.21 | NA |
| Year Ago EPS | 0.25 | 0.28 | NA | 1.21 |
| EPS Growth | 24.00% | 17.86% | NA | 8.26% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| NOVOZYMES A/S | NVZMY | 34.26 | |
|
| AMER PAC CORP | APFC | 27.49 | |
|
| AMER VANGUARD | AVD | 30.63 | |
|
| FERRO CORP | FOE | 7.04 | |
|
| MINERAL TECH | MTX | 42.81 | |
|
| QUAKER CHEMICAL | KWR | 65.72 | |
|
| BALCHEM CP CL-B | BCPC | 47.75 | |
|
| ECOLAB INC | ECL | 89.09 | |
|
| KMG CHEMICALS | KMG | 21.30 | |
|
| MEXICHEM SAB DE | MXCHY | 9.32 | |
|
Sector:Basic Materials>> Industry:CHEM-SPECIALTY
COMPARE TICKER vs. Its Peers
Zacks Commentary
Rockwood Repays Sachtleben Debts
Mar 27, 2013
American Vanguard Tops in 4Q
Mar 07, 2013
Chemtura Misses Squarely
Mar 01, 2013
Rockwood Hikes Dividend
Feb 26, 2013
Valspar Reaffirmed at Neutral
Feb 20, 2013
Rockwood to Control Sachtleben
Feb 19, 2013
Sigma-Aldrich Hikes Dividend
Feb 19, 2013
Sigma-Aldrich Inks Deal with Olink
Feb 14, 2013
Financials
| EPS TTM | 1.01 |
| Sales | 1,870 |
| Net Income | 324 |
| Price/Earnings | 33.92 |
| Price/Book | 6.01 |
| Price/Cash Flow | NA |
| Price/Sales | 4.91 |
News
Novozymes Q2 Net Profit Up 9% - Benzinga
Aug 16, 2012
Earnings Roundup - Benzinga
Jan 19, 2012
Novozymes Reports Downbeat Q4 Net Profit - Benzinga
Jan 19, 2012
Broker Recommendations
| Current ABR | 3.00 |
| ABR (Last Week) | 3.00 |
| # of recs in ABR | 2 |
| Average Target Price | 28.30 |
| Industry Rank by ABR | 191 out of 265 |
| Rank in Industry | 16 out of 24 |
